注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
scPharmaceuticals Inc.是一家制药公司。该公司专注于开发和商业化旨在降低医疗成本和改善健康结果的产品。该公司在内部和通过战略合作伙伴关系开发产品和解决方案,旨在扩大和推进特定急性病症的门诊护理。其主要候选产品FUROSCIX由其通过体内输液器输送的呋塞米配方组成,正在开发用于治疗充血性心力衰竭、肝硬化和肾病(包括肾病综合征)成人患者的水肿。其产品项目还包括scCeftriaxone和scCarbapenem。其scCeftriaxone是一种静脉注射抗生素,用于治疗由革兰氏阳性和革兰氏阴性微生物引起的感染。其scCarbapenem项目是一种静脉注射抗生素,用于治疗由革兰氏阴性菌引起的感染。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Jack A. Khattar | 63 | 2016 | Independent Chairman of the Board |
Klaus R. Veitinger | 62 | 2017 | Independent Director |
Dan Bensimhon | - | - | Member of Scientific Advisory Board |
William S. Weintraub | - | - | Member of Scientific Advisory Board |
William T. Abraham | 64 | 2021 | Independent Director |
Mette Kirstine Agger | 60 | 2014 | Independent Director |
Leonard D. Schaeffer | 78 | 2014 | Independent Director |
Marvin A. Konstam | - | - | Member of Scientific Advisory Board |
Frederick M. Hudson | 79 | 2018 | Independent Director |
John H. Tucker | 61 | 2016 | President, CEO, Principal Executive Officer & Director |
Sara M. Bonstein | 43 | 2020 | Independent Director |
Minnie V. Baylor-Henry | 76 | 2018 | Independent Director |
Stuart Russell | - | - | Member of Scientific Advisory Board |
G. Michael Felker | - | - | Member of Scientific Advisory Board |
William Franklin Peacock | - | - | Member of Scientific Advisory Board |
James E. Udelson | - | - | Member of Scientific Advisory Board |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核